Updates to the list of medicines that cannot be parallel exported from the UK

Updates to the list of medicines that cannot be parallel exported from the UK

November 18, 2020

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have updated the list of medicines which must not be parallel exported from the UK.

From 7 November 2020, two medicines have been added to the list: Dabigatran etexilate and Semaglutide tablets.

View the list of medicines that cannot be parallel exported from the UK (as of 7 November)

In October 2019, the DHSC wrote to holders of a wholesalers dealers licence to remind them of their responsibilities to ensure the continued supply of medicines to meet the needs of UK patients. The letter also includes the list of medicinal products which “cannot be supplied for parallel export or parallel distribution from the UK or hoarded (held back)” for the time being.

The government has produced guidance on export and hoarding of restricted medicines for wholesalers dealers licence holders to remind them of their responsibilities to ensure the continued supply of medicines to meet the needs of UK patients. In October 2019, the DHSC also wrote a letter to holders of a wholesale dealer licence about the restrictions placed on parallel exports. The letter includes the following criteria for restricting the parallel export of a medicine:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.

Hoarding or exporting a medicine on the list is considered a breach of regulation 43(2) of the Human Medicines Regulations 2012 and a contravention of the wholesale dealer licence and may lead to regulatory action by the MHRA, which could include immediate suspension of the wholesale dealer licence.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

NHSBSA now circulate to pharmacies via email a link to the monthly supply update hosted on SPS

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.



Posted in: ,


More Latest News >